Synthalin

Synthalin
Names
	Preferred IUPAC name N,N′′′-(Decane-1,10-diyl)diguanidine
Identifiers
CAS Number	111-23-9 ;
3D model (JSmol)	Interactive image;
ChEBI	CHEBI:84338 ;
ChEMBL	ChEMBL1194310 ;
ChemSpider	60335 ;
ECHA InfoCard	100.003.499
EC Number	203-848-1;
MeSH	synthalin+A
PubChem CID	66977;
UNII	ZEA6Y34XYT ;
CompTox Dashboard (EPA)	DTXSID50911935 ;
	InChI InChI=1S/C12H28N6/c13-11(14)17-9-7-5-3-1-2-4-6-8-10-18-12(15)16/h1-10H2,(H4,13,14,17)(H4,15,16,18) Key: OZZMUVKANAPKGI-UHFFFAOYSA-N ;
	SMILES NC(=N)NCCCCCCCCCCNC(N)=N;
Properties
Chemical formula	C12H28N6
Molar mass	256.398 g·mol−1
Pharmacology
Routes of; administration	Oral
Related compounds
Related compounds	Spermine; Arginylglycylaspartic acid; Dibutylhexamethylenediamine;
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Synthalin was an oral anti-diabetic drug. Discovered in 1926 it was marketed in Europe by Schering AG of Berlin as a synthetic drug with insulin-like properties that could be taken orally. However, it was toxic to the liver and kidney and was withdrawn from the market in the early 1940s.